Overview

Induction Chemotherapy Followed by Short Course Radiotherapy in Rectal Cancer

Status:
Active, not recruiting
Trial end date:
2023-11-30
Target enrollment:
Participant gender:
Summary
A Single-arm phase II trial evaluating induction chemotherapy with FOLFIRINOXm followed by short course radiotherapy (RT) in locally advanced rectal carcinoma
Phase:
Phase 2
Details
Lead Sponsor:
Salah Azaïz Cancer Institute
Treatments:
Fluorouracil
Folfirinox
Irinotecan
Oxaliplatin